SABBY MANAGEMENT, LLC Buys 3, Sells 2 in 4th Quarter

SABBY MANAGEMENT, LLC recently filed their 13F report for the fourth quarter of 2022, which ended on 2022-12-31.

The 13F report details which stocks were in a guru’s equity portfolio at the end of the quarter, though investors should note that these filings are limited in scope, containing only a snapshot of long positions in U.S.-listed stocks and American depository receipts as of the quarter’s end. They are not required to include international holdings, short positions or other types of investments. Still, even this limited filing can provide valuable information.

10 Mountainview Road Upper Saddle River, NJ 07458

As of the latest 13F report, the guru’s equity portfolio contained 108 stocks valued at a total of $76.00Mil. The top holdings were NVCT(5.81%), TBLT(3.01%), and DOGZ(2.69%).

According to GuruFocus data, these were SABBY MANAGEMENT, LLC’s top five trades of the quarter.

Bright Green Corp


SABBY MANAGEMENT, LLC reduced their investment in NAS:BGXX by 2,900,078 shares. The trade had a 4.54% impact on the equity portfolio. During the quarter, the stock traded for an average price of $0.58.

On 02/17/2023, Bright Green Corp traded for a price of $0.9801 per share and a market cap of $165.97Mil. The stock has returned 0.00% over the past year.

GuruFocus gives the company a financial strength rating of 7 out of 10 and a profitability rating of 2 out of 10.

In terms of valuation, Bright Green Corp has a price-book ratio of 12.25 and a EV-to-Ebitda ratio of -6.67.

TuanChe Ltd


The guru established a new position worth 2,429,370 shares in NAS:TC, giving the stock a 2.68% weight in the equity portfolio. Shares traded for an average price of $4.2 during the quarter.

On 02/17/2023, TuanChe Ltd traded for a price of $0.68 per share and a market cap of $16.71Mil. The stock has returned -69.78% over the past year.

GuruFocus gives the company a financial strength rating of 5 out of 10 and a profitability rating of 3 out of 10.

In terms of valuation, TuanChe Ltd has a price-book ratio of 0.61, a EV-to-Ebitda ratio of -0.86 and a price-sales ratio of 0.24.

The price-to-GF Value ratio is 0.58, earning the stock a GF Value rank of 8.

iShares Russell 2000 ETF


The guru established a new position worth 11,000 shares in ARCA:IWM, giving the stock a 2.53% weight in the equity portfolio. Shares traded for an average price of $177.2 during the quarter.

On 02/17/2023, iShares Russell 2000 ETF traded for a price of $192.6208 per share and a market cap of $56.39Bil. The stock has returned -3.04% over the past year.

There is insufficient data to calculate the stock’s financial strength and profitability ratings.

In terms of valuation, iShares Russell 2000 ETF has a price-earnings ratio of 11.60 and a price-book ratio of 2.01.

Huadi International Group Co Ltd


The guru established a new position worth 291,609 shares in NAS:HUDI, giving the stock a 1.96% weight in the equity portfolio. Shares traded for an average price of $19.53 during the quarter.

On 02/17/2023, Huadi International Group Co Ltd traded for a price of $5.03 per share and a market cap of $71.62Mil. The stock has returned -74.26% over the past year.

GuruFocus gives the company a financial strength rating of 6 out of 10 and a profitability rating of 4 out of 10.

In terms of valuation, Huadi International Group Co Ltd has a price-earnings ratio of 33.76, a price-book ratio of 1.35, a EV-to-Ebitda ratio of 18.23 and a price-sales ratio of 0.87.

BioLine Rx Ltd


SABBY MANAGEMENT, LLC reduced their investment in NAS:BLRX by 1,282,115 shares. The trade had a 1.72% impact on the equity portfolio. During the quarter, the stock traded for an average price of $0.74.

On 02/17/2023, BioLine Rx Ltd traded for a price of $0.6052 per share and a market cap of $34.71Mil. The stock has returned -64.81% over the past year.

GuruFocus gives the company a financial strength rating of 7 out of 10 and a profitability rating of 1 out of 10.

In terms of valuation, BioLine Rx Ltd has a price-book ratio of 0.67 and a EV-to-Ebitda ratio of 0.53.


Please note, the numbers and facts quoted are as of the writing of this article and may not factor in the latest trading data or company announcements.

When GuruFocus covers insider information, we only track open market or the private purchase and sale of common stock with the transaction code of P or S. Therefore, all the transactions mentioned in this article are only the ones with transaction code of P or S.

Want to provide feedback on this article? Have questions or concerns? Get in touch with us here, or email us at [email protected]!

This article is general in nature and does not represent the opinions of GuruFocus or any of its affiliates. This article is not intended to be financial advice, nor does it constitute investment advice or recommendations. It was written without regard to your individual situation or financial goals. We aim to bring you fundamental, data-driven analysis, The information on this site is in no way guaranteed for completeness, accuracy or in any other way.